跳转至内容
Merck
CN
  • Consequences of misdiagnosis and mismanagement of Takotsubo cardiomyopathy.

Consequences of misdiagnosis and mismanagement of Takotsubo cardiomyopathy.

Acute cardiac care (2012-12-12)
Chirayu Vyas, Sanjay Shah, Sameer Pancholy, Tejas Patel, Isam Moussa
摘要

We report a patient who presented with takotsubo cardiomyopathy but was misdiagnosed as an anterior wall ST elevation myocardial infarction (AWMI). We illustrate how misdiagnosis led to mismanagement by initiating intravenous inotropic agents that led to further hemodynamic compromise. Subsequent withdrawal of the inotropic agents and simultaneous administration of oral metoprolol therapy led to hemodynamic and clinical improvement re-affirming the diagnosis of takotsubo cardiomyopathy.

材料
Product Number
品牌
产品描述

Supelco
酒石酸美托洛尔标准液 酒石酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®